Search Results 1731-1740 of 18722 for autoimmune hepatitis

  1. Konstantinos N. Lazaridis, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic gastroenterologist Konstantinos N. Lazaridis, M.D., researches factors that may cause rare chronic cholestatic liver diseases.

  2. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    Has an active autoimmune disease that has ... Has a known history of hepatitis B (defined as hepatitis ... Note: No testing for hepatitis B or hepatitis C is ...

  3. Trial of Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus - Mayo Clinic

    Autoimmune pancreatitis, obstructive pancreatitis, and prior surgery of pancreas. Any condition which could jeopardize participant safety as per ...

  4. A Study to Evaluate Pembrolizumab, Ixazomib Citrate, and Dexamethasone to Treat Participants with Relapsed Multiple Myeloma - Mayo Clinic

    Has active autoimmune disease that has required systemic ... Has known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis ...

  5. Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab in Refractory Cancer - Mayo Clinic

    Patients with history of autoimmune ... Known history of hepatitis B or C infection or known positive test for hepatitis B surface antigen or core antigen, or ...

  6. Clinical trials - Gastroenterology and Hepatology

    ... liver disease for investigations into the molecular pathogenesis of cirrhosis, liver cancer, and end-stage liver disease. Pagination Clinical studies. Prev ...

  7. Hepatitis A - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  8. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis - Mayo Clinic

    Positive hepatitis BsAg or hepatitis C antibody ... Tocilizumab - a novel therapy for non-organ-specific autoimmune diseases. ... autoimmune diseases. An IFN gene ...

  9. Publications - Ricardo J. Pagan, M.D. - Mayo Clinic

    Herpes Simplex Virus Type 2 Hepatitis: An Uncommon Cause of Persistent Fever ... Liver Disease. Case Rep Oncol. 2024 Jan-Dec; 17 (1):788-796 Epub 2024 ...

  10. A Study of LNK01002 in Patients With Primary (PMF) or Secondary Myelofibrosis (PV-MF, ET-MF) or Acute Myeloid Leukemia - Mayo Clinic

    Known history of clinically significant liver disease, including viral or other hepatitis: Patients with hepatitis B or hepatitis C may be enrolled if they ...